Studies of cyclodextrin inclusion complexes. IV. The pulmonary absorption of salbutamol from a complex with 2-hydroxypropyl-β-cyclodextrin in rabbits

No abstract is available for this paper.

• Publication year

  1991

• Venue

  International Journal of Pharmaceutics

• Publication date

  1991-11-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0378-5173(91)90331-H
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Studies of cyclodextrin inclusion complexes. III. The pulmonary absorption of β-, DM-β- and HP-β-cyclodextrins in rabbits

  1991cited by this paper
• Studies of cyclodextrin inclusion complexes. II. Molecular modelling and 1H-NMR evidence for the salbutamol-β-cyclodextrin complex

  1990cited by this paper
• Studies of cyclodextrin inclusion complexes. I. The salbutamol-cyclodextrin complex as studied by phase solubility and DSC

  1990cited by this paper
• THE ABSORPTION OF β‐, DM‐β‐ AND HP‐β‐CYCLODEXTRINS FROM THE RABBIT LUNG

  1990cited by this paper
• Clinical pharmacokinetics : concepts and applications

  1989cited by this paper
• Pharmacokinetics and metabolism of salbutamol in premature labour.

  1987cited by this paper
• Pharmacokinetics of inhaled salbutamol in patients with cystic fibrosis versus healthy young adults.

  1987cited by this paper
• Reversed-phase high-performance liquid chromatographic determination of salbutamol in rabbit plasma.

  1984cited by this paper
• Absorption of drugs by the lung.

  1976cited by this paper
• MULTIPLE RANGE AND MULTIPLE F TESTS

  1955cited by this paper

• Cannabidiol and Hydroxypropyl-β-Cyclodextrin for the Development of Deflated Spherical-Shaped Inhalable Powder

  2025cites this paper
• Repurposing Bedaquiline for Effective Non-Small Cell Lung Cancer (NSCLC) Therapy as Inhalable Cyclodextrin-Based Molecular Inclusion Complexes

  2021cites this paper
• Safety of inhaled ivermectin as a repurposed direct drug for treatment of COVID-19: A preclinical tolerance study

  2021cites this paper
• Quantifying the hygroscopic properties of cyclodextrin containing aerosol for drug delivery to the lungs.

  2020cites this paper
• Administration Routes for Nano Drugs and Characterization of Nano Drug Loading

  2019cites this paper
• Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles

  2017cites this paper
• “A Short Review on Cyclodextrin Inclusion Complexes: Synthesis, Characterization and Their Applications”

  2017cites this paper
• In vitro dissolution-permeation evaluation of an electrospun cyclodextrin-based formulation of aripiprazole using μFlux™.

  2015cites this paper
• Cyclodextrins, blood-brain barrier, and treatment of neurological diseases.

  2014cites this paper
• Study of aerodynamic and release properties of inhaled particles containing cyclodextrins

  2014cites this paper
• Polycationic amphiphilic cyclodextrin-based nanoparticles for therapeutic gene delivery.

  2011cites this paper
• Cyclodextrin-based gene delivery systems.

  2011cites this paper
• Excipients Utilized for Modifying Pulmonary Drug Release

  2011cites this paper
• Optimisation of spray-drying process variables for dry powder inhalation (DPI) formulations of corticosteroid/cyclodextrin inclusion complexes.

  2009cites this paper
• Cyclodextrins as a potential carrier in drug nebulization

  2009cites this paper
• Amorphous cyclosporin nanodispersions for enhanced pulmonary deposition and dissolution.

  2008cites this paper
• Cyclodextrins as a potential carrier in drug nebulization.

  2004cites this paper
• Cyclodextrin enhanced transdermal delivery of piroxicam and carboxyfluorescein by electroporation.

  2004cites this paper
• Improvement of pulmonary absorption of cyclopeptide FK224 in rats by co-formulating with beta-cyclodextrin.

  2003cites this paper
• Targeting caveolae for vesicular drug transport.

  2003cites this paper
• The in vitro Pulmonary Deposition of a Budesonide γ-Cyclodextrin Inclusion Complex

  2002cites this paper
• Prodrug to probe solution HFA pMDI formulation and pulmonary esterase activity.

  2000cites this paper
• Effect of carboxymethyl-β-cyclodextrin on the hydrophobicity parameters of steroidal drugs

  1999cites this paper
• Interaction of some steroid drugs with β-cyclodextrin polymer

  1999cites this paper
• Inclusion complex formation of steroidal drugs with hydroxypropyl-beta-cyclodextrin studied by charge-transfer chromatography.

  1998cites this paper
• Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation.

  1997cites this paper
• Complexes d'insertion de beta-2-adrenergiques absorbes par les muqueuses buccales

  1997cites this paper
• The Influence of Sodium Glycocholate and Other Additives on the in vivo Transfection of Plasmid DNA in the Lungs

  1996cites this paper
• Inclusion complex formation of antisense nucleotides with hydroxypropyl-β-cyclodextrin

  1996cites this paper
• Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery.

  1996cites this paper
• The controlled delivery of drugs to the lung

  1995cites this paper